![Bernd Hentsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernd Hentsch
Directeur/Membre du Conseil chez
G2M Cancer Drugs AG
Profil
Bernd Hentsch is currently a Director at G2M Cancer Drugs AG since 2001.
He was previously a Chief Development Officer at 4SC AG and TopoTarget UK Ltd. Dr. Hentsch holds a doctorate degree from Julius-Maximilians-Universität Würzburg.
Postes actifs de Bernd Hentsch
| Sociétés | Poste | Début |
|---|---|---|
G2M Cancer Drugs AG
 G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Researches new anti-cancer therapeutics and develops selected late-stage products | Directeur/Membre du Conseil | 01/01/2001 |
Anciens postes connus de Bernd Hentsch
| Sociétés | Poste | Fin |
|---|---|---|
| 4SC AG | Corporate Officer/Principal | - |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Corporate Officer/Principal | - |
Formation de Bernd Hentsch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
G2M Cancer Drugs AG
G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Researches new anti-cancer therapeutics and develops selected late-stage products | Commercial Services |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Retail Trade |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
